SERAQ CONTROLS FOR VIRAL SEROLOGY ASSAYS
SERAQ CONTROLS FOR SYPHILIS ASSAYS
VIRAQ CHECK AND TREND CONTROLS FOR HBV/HCV/HIV NAT ASSAYS
VIRAQ CHECK CONTROLS FOR NON-ENVELOPED VIRUS NAT ASSAYS
VIRAQ CHECK CONTROLS FOR ARBOVIRUS NAT ASSAYS
ANALYTICAL SENSITIVITY PANELS FOR HBV-DNA ASSAYS
ANALYTICAL SENSITIVITY PANELS FOR HCV-RNA ASSAYS
ANALYTICAL SENSITIVITY PANELS FOR HIV-RNA ASSAYS
NON-ENVELOPED VIRUS STANDARD DILUTION PANELS
MULTIPLE VIRAL GENOTYPE REFERENCE PANELS FOR VIRAL NAT ASSAYS
ARBOVIRUS STANDARD DILUTION PANELS
VIRAQ QUANT CONTROLS FOR VIRAL LOAD ASSAYS
LINEARITY PANELS FOR VIRAL LOAD ASSAYS
In 1992 we took on the challenge of organising the first international proficiency study for viral NAT laboratories. The outcome of these studies demonstrated an urgent need for standardisation and quality control of these test methods. Since then we have endeavoured to make a contribution to evaluation of blood screening assays by providing reference panels and controls prepared from stable viral standards. Now, almost thirty years later, we have demonstrated that our manufacturing process of reference sample from deep frozen plasma standards, has provided consistent quality control products in multiple settings. Over the years we have continued to further characterise our standards, demonstrating that our calibration in nucleic acid copies are close to true virion numbers. This provides a foundation for understanding the benefit of blood screening assays in reducing viral transmission risk. With our reference standards and statistical tools for evaluation of blood screening assays we aim to provide the necessary and essential components of a post-market surveillance system of blood screening assays. With the provision of these products and services, our company hopes to contribute to, and improve blood safety.